Invivoscribe® Expands IVDR Portfolio with IdentiClone® Dx IGH Assay Certification
· Financial Post
IdentiClone® Dx IGH is the first IVDR-certified assay for the detection of clonal immunoglobulin gene rearrangements in patients with suspected B-cell lymphoproliferative disease. Read More
Visit newsbetsport.bond for more information.